RU2676486C1 - Способы, предназначенные для синтеза аналогов галихондрина b - Google Patents

Способы, предназначенные для синтеза аналогов галихондрина b Download PDF

Info

Publication number
RU2676486C1
RU2676486C1 RU2016124265A RU2016124265A RU2676486C1 RU 2676486 C1 RU2676486 C1 RU 2676486C1 RU 2016124265 A RU2016124265 A RU 2016124265A RU 2016124265 A RU2016124265 A RU 2016124265A RU 2676486 C1 RU2676486 C1 RU 2676486C1
Authority
RU
Russia
Prior art keywords
eribulin
pharmaceutically acceptable
acceptable salt
paragraphs
intermediate product
Prior art date
Application number
RU2016124265A
Other languages
English (en)
Russian (ru)
Inventor
Брайан М. ЛЬЮИС
Юнбо Ху
Хоймин ЧЖАН
Хироюки ТИБА
Юки КОМАЦУ
Original Assignee
Эйсай Ар Энд Ди Менеджмент Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйсай Ар Энд Ди Менеджмент Ко., Лтд. filed Critical Эйсай Ар Энд Ди Менеджмент Ко., Лтд.
Application granted granted Critical
Publication of RU2676486C1 publication Critical patent/RU2676486C1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2016124265A 2013-12-06 2014-12-05 Способы, предназначенные для синтеза аналогов галихондрина b RU2676486C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361912714P 2013-12-06 2013-12-06
US61/912,714 2013-12-06
PCT/US2014/068834 WO2015085193A1 (en) 2013-12-06 2014-12-05 Methods useful in the synthesis of halichondrin b analogs

Publications (1)

Publication Number Publication Date
RU2676486C1 true RU2676486C1 (ru) 2018-12-29

Family

ID=53270478

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016124265A RU2676486C1 (ru) 2013-12-06 2014-12-05 Способы, предназначенные для синтеза аналогов галихондрина b

Country Status (13)

Country Link
US (4) US9303039B2 (https=)
EP (2) EP3077399B1 (https=)
JP (3) JP6443812B2 (https=)
CN (1) CN105916861B (https=)
BR (1) BR112016012237B1 (https=)
CA (1) CA2931788C (https=)
ES (1) ES2723355T3 (https=)
HU (1) HUE043088T2 (https=)
IL (4) IL245661A0 (https=)
MX (3) MX376869B (https=)
RU (1) RU2676486C1 (https=)
SG (2) SG10201805024YA (https=)
WO (1) WO2015085193A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2522663T1 (sl) 2004-06-03 2015-08-31 Eisai R&D Management Co., Ltd. Vmesne spojine za pripravo halihondrina B
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
CA2720632C (en) 2008-04-04 2016-12-20 Eisai R&D Management Co., Ltd. Halichondrin b analogs
RU2579511C2 (ru) 2010-01-26 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производные фуро[3,2-в]пирана, применимые в синтезе аналогов
BR112016009452B1 (pt) * 2013-11-04 2022-06-07 Eisai R&D Management Co., Ltd Métodos de preparar intermediários na síntese de eribulina, métodos de preparar eribulina e mesilato de eribulina, e compostos intermediários
EP3077399B1 (en) * 2013-12-06 2019-02-20 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
CN108601760A (zh) * 2016-02-12 2018-09-28 卫材R&D管理有限公司 艾日布林的合成中的中间体及相关的合成方法
PE20231050A1 (es) 2016-03-02 2023-07-11 Eisai Randd Man Co Ltd Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso
KR102404629B1 (ko) 2016-06-30 2022-06-02 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 중간체
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
SMT202200455T1 (it) * 2017-04-05 2023-01-13 Harvard College Composto macrociclico e relativi usi
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
WO2018217894A1 (en) * 2017-05-24 2018-11-29 Eisai R&D Management Co., Ltd. Fluorine-labelled halichondrin derivatives and related methods of synthesis
WO2019010363A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College HALICHONDRINES SYNTHESIS
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
CN109694379B (zh) * 2017-10-24 2020-09-11 江苏恒瑞医药股份有限公司 用于制备艾日布林的中间体及其制备方法
WO2019099646A1 (en) 2017-11-15 2019-05-23 President And Fellows Of Harvard College Macrocyclic compounds and uses thereof
WO2019097073A1 (en) 2017-11-20 2019-05-23 Basilea Pharmaceutica International AG Pharmaceutical combinations for use in the treatment of neoplastic diseases
IL275729B2 (en) 2018-01-03 2023-09-01 Eisai R&D Man Co Ltd Prins reaction and compounds useful in the synthesis of helicondrin macrolides and their analogs
WO2020016847A2 (en) * 2018-07-20 2020-01-23 Dr. Reddy’S Laboratories Limited Purification process for preparation of eribulin and intermediates thereof
CN113166096A (zh) * 2018-10-09 2021-07-23 雷迪博士实验室有限公司 制备艾立布林的方法及其中间体
US12522611B2 (en) * 2018-11-28 2026-01-13 Natco Pharma Limited Process for the preparation of high pure Eribulin and its Mesylate salt
US11447499B2 (en) 2019-06-14 2022-09-20 Rk Pharma Inc. Process for the preparation of eribulin mesylate intermediate
WO2022101931A1 (en) * 2020-11-10 2022-05-19 Natco Pharma Limited Process for the preparation of eribulin and its intermediates
CN113354659B (zh) * 2021-06-08 2022-04-08 江苏慧聚药业股份有限公司 甲磺酸艾日布林的合成
CN114380840B (zh) * 2022-01-27 2024-01-26 江苏慧聚药业股份有限公司 艾日布林的合成
WO2025106586A1 (en) * 2023-11-13 2025-05-22 Luxvitae Therapeutics Inc. Macrocyclic ketone compounds and applications thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194586B1 (en) * 1996-09-06 2001-02-27 Eli Lilly And Company Selective sulphonation of the primary alcohol of a diol containing both primary and secondary alcohols
US20070244187A1 (en) * 2004-06-03 2007-10-18 Eisai Co., Ltd Intermediates for the Preparation of Halichondrin B
WO2009124237A1 (en) * 2008-04-04 2009-10-08 Eisai R&D Management Co., Ltd. Halichondrin b analogs
RU2489437C2 (ru) * 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU652180A1 (ru) 1975-12-16 1979-03-15 Краснодарский политехнический институт 1(Фурил-2,)-2-(2-,, формилфурил-5,, ) этилен или его метильное производное как промежуточный продукт дл синтеза фуран-2,5-дикарбоновой кислоты и способ его получени
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
TW255880B (https=) 1992-09-09 1995-09-01 Hoechst Ag
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
JP4454151B2 (ja) 1998-06-17 2010-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 大環状類似体及びそれらの使用並びに調製方法
CA2822994C (en) * 2004-06-03 2016-09-27 Eisai R&D Management Co., Ltd. Intermediates for the preparation of analogs of halichondrin b
US20060045846A1 (en) 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
US20060154312A1 (en) 2004-12-09 2006-07-13 Sergei Agoulnik Tubulin isotype screening in cancer therapy using halichondrin B analogs
WO2008010776A1 (en) 2006-07-21 2008-01-24 Agency For Science, Technology And Research Aigialomycin d and derivatives thereof and their use in treating cancer or malaria or a microbial infection
US8119839B2 (en) 2007-07-20 2012-02-21 Yamada Apiculture Center, Inc. Carboxylic acid and antidepressant composition containing the same as active ingredient
CN101910180A (zh) 2007-11-16 2010-12-08 卫材R&D管理有限公司 用于软海绵素b类似物合成的新颖中间体和用于该中间体的新颖脱磺酰化反应
JP5371091B2 (ja) 2009-01-23 2013-12-18 三菱レイヨン株式会社 モノスルホン酸エステルの製造方法
RU2579511C2 (ru) 2010-01-26 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производные фуро[3,2-в]пирана, применимые в синтезе аналогов
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
WO2013078559A1 (en) 2011-11-30 2013-06-06 Alphora Research Inc. Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
EP3016957A4 (en) 2013-07-03 2016-11-30 Alphora Res Inc SYNTHETIC METHOD FOR THE PRODUCTION OF CYCLIC C1-KETO ANALOGUE OF HALICHONDRIN B AND USEFUL INTERMEDIATE PRODUCTS, INCLUDING INTERMEDIATE PRODUCTS WITH -SO2- (P-TOLYL) GROUPS
BR112016009452B1 (pt) 2013-11-04 2022-06-07 Eisai R&D Management Co., Ltd Métodos de preparar intermediários na síntese de eribulina, métodos de preparar eribulina e mesilato de eribulina, e compostos intermediários
EP3077399B1 (en) * 2013-12-06 2019-02-20 Eisai R&D Management Co., Ltd. Methods useful in the synthesis of halichondrin b analogs
MX392296B (es) 2015-05-07 2025-03-24 Eisai R&D Man Co Ltd Reacciones de macrociclizacion e intermediarios y otros fragmentos utiles en la sintesis de macrolidos de halicondrina.
CN108601760A (zh) 2016-02-12 2018-09-28 卫材R&D管理有限公司 艾日布林的合成中的中间体及相关的合成方法
KR102404629B1 (ko) 2016-06-30 2022-06-02 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 중간체

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194586B1 (en) * 1996-09-06 2001-02-27 Eli Lilly And Company Selective sulphonation of the primary alcohol of a diol containing both primary and secondary alcohols
US20070244187A1 (en) * 2004-06-03 2007-10-18 Eisai Co., Ltd Intermediates for the Preparation of Halichondrin B
RU2489437C2 (ru) * 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
WO2009124237A1 (en) * 2008-04-04 2009-10-08 Eisai R&D Management Co., Ltd. Halichondrin b analogs

Also Published As

Publication number Publication date
ES2723355T3 (es) 2019-08-26
JP2019031530A (ja) 2019-02-28
HUE043088T2 (hu) 2019-08-28
IL245661A0 (en) 2016-06-30
US9695188B2 (en) 2017-07-04
US10450324B2 (en) 2019-10-22
MX376869B (es) 2025-03-07
MX2016006891A (es) 2017-06-12
IL273736B (en) 2021-03-25
CN105916861B (zh) 2018-12-14
CA2931788C (en) 2022-05-24
MX2019011926A (es) 2019-11-18
MX384292B (es) 2025-03-14
JP2016540752A (ja) 2016-12-28
IL281275B (en) 2021-12-01
JP6634135B2 (ja) 2020-01-22
US20150158881A1 (en) 2015-06-11
EP3077399B1 (en) 2019-02-20
US20190010166A1 (en) 2019-01-10
JP6443812B2 (ja) 2018-12-26
IL265640B (en) 2020-04-30
IL281275A (en) 2021-04-29
SG11201604545XA (en) 2016-07-28
JP6905041B2 (ja) 2021-07-21
JP2020059739A (ja) 2020-04-16
US9303039B2 (en) 2016-04-05
EP3077399A4 (en) 2017-05-10
EP3077399A1 (en) 2016-10-12
EP3505520A1 (en) 2019-07-03
IL273736A (en) 2020-05-31
WO2015085193A1 (en) 2015-06-11
BR112016012237B1 (pt) 2023-02-07
US20170298078A1 (en) 2017-10-19
US20160176895A1 (en) 2016-06-23
CN105916861A (zh) 2016-08-31
IL265640A (en) 2019-05-30
SG10201805024YA (en) 2018-07-30
US10030032B2 (en) 2018-07-24
MX370611B (es) 2019-12-18
MX2020004855A (es) 2021-07-08
BR112016012237A2 (https=) 2017-08-08
CA2931788A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
RU2676486C1 (ru) Способы, предназначенные для синтеза аналогов галихондрина b
CA2861150C (en) Morphinan derivative
EP2640730B1 (en) Processes for preparation of everolimus and intermediates thereof
EP3527573B9 (en) Synthesis of polycyclic-carbamoylpyridone compounds
CN103517911B (zh) 雷帕霉素在c-42位上的区域选择性酰化
CN106977415A (zh) 一种沙库必曲的中间体及其制备方法
CN109694379B (zh) 用于制备艾日布林的中间体及其制备方法
EP3207041B1 (en) An improved process for the preparation of lurasidone hydrochloride
JP6528251B2 (ja) (s)−1−((2r,3r,4s,5s)−5−アリル−3−メトキシ−4−(トシルメチル)テトラヒドロフラン−2−イル)−3−アミノプロパン−2−オールの結晶性誘導体
CN108610306B (zh) 一种2h-1,4-噻嗪-3(4h)-酮衍生物的合成方法
EP4524145A1 (en) Method for preparing 4?-thio-5-aza-2?-deoxycytidine
KR101346555B1 (ko) 9-히드록시-3-(2-클로로에틸)-2-메틸-6,7,8,9-테트라히드로-4H-피리도[1,2-a]피리미딘-4-온의 제조방법
HK40044746A (en) Synthesis of polycyclic-carbamoylpyridone compounds
Alaa et al. Tadalafil
HK40011503A (en) Synthesis of polycyclic-carbamoylpyridone compounds
HK40011503B (en) Synthesis of polycyclic-carbamoylpyridone compounds
FR3022907A1 (fr) Derives d'osw-1 et leur utilisation en tant que medicament
HK1232880A1 (en) Synthesis of polycyclic-carbamoylpyridone compounds